Literature DB >> 26854254

A two-step binding mechanism for the self-binding peptide recognition of target domains.

Chao Yang1, Shilei Zhang, Zhengya Bai, Shasha Hou, Di Wu, Jian Huang, Peng Zhou.   

Abstract

Self-binding peptides (SBPs) represent a novel biomolecular phenomenon spanning between folding and binding, where a short peptide segment within a monomeric protein fulfills biological functions by dynamically binding to/unbinding from its target domain in the same monomer. Here, we were able to quantitatively reconstruct the complete structural dynamics picture of binding of free SBPs to their target domains for five representative SBP systems by carrying out the state-of-the-art molecular dynamics (MD) simulations. In the picture, a two-step binding mechanism for SBP-domain recognition and association was proposed, which includes a fast, nonspecific diffusive phase and a slow, specific organizational phase. The electrostatic interactions and desolvation effects play a predominant role in the first phase that leads to the formation of a metastable encounter complex, while conformational rearrangement is observed in the second phase to optimize the exquisite network of nonbonded chemical forces such as hydrogen bonds and salt bridges across the complex interface. From an energetic point of view, a funnel-shape enthalpy landscape steers these SBPs towards their native bound state and thus facilitates the binding process. However, the binding exhibits typical enthalpy-entropy compensation due to the high flexibility of peptides that results in a relatively low affinity for SBP-domain binding and forces the SBP systems to rapidly switch between the bound and unbound states. In addition, slight conformational changes in the target domain and/or in the polypeptide linker between the domain and peptide can significantly affect the energetic properties and dynamic behavior of the fine-tuned binding process of SBP-domain recognition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26854254     DOI: 10.1039/c5mb00800j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  11 in total

1.  Electrostatic mechanism of V600E mutation-induced B-Raf constitutive activation in colorectal cancer: molecular implications for the selectivity difference between type-I and type-II inhibitors.

Authors:  Tie Liu; Zhaoshun Wang; Peng Guo; Na Ding
Journal:  Eur Biophys J       Date:  2018-09-14       Impact factor: 1.733

2.  Rational redesign of a cation···π···π stacking at cardiovascular Fbw7-Skp1 complex interface and its application for deriving self-inhibitory peptides to disrupt the complex interaction.

Authors:  Jing Zhou; Yao-Sheng Wang
Journal:  J Mol Model       Date:  2017-09-26       Impact factor: 1.810

3.  Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.

Authors:  Min Han; Dongdong Sun
Journal:  J Comput Aided Mol Des       Date:  2019-06-15       Impact factor: 3.686

4.  Computational redesign of human respiratory syncytial virus epitope as therapeutic peptide vaccines against pediatric pneumonia.

Authors:  Xiangxiang Shi; Jun Zheng; Tingting Yan
Journal:  J Mol Model       Date:  2018-03-02       Impact factor: 1.810

5.  Rational design of stapled helical peptides as antidiabetic PPARγ antagonists to target coactivator site by decreasing unfavorable entropy penalty instead of increasing favorable enthalpy contribution.

Authors:  Yang Zhang; Jie Wang; Wenchao Li; Ying Guo
Journal:  Eur Biophys J       Date:  2022-09-04       Impact factor: 2.095

6.  Grafting, Stripping and Stapling of Helical Peptides from the Dimerization Interface of ONFH-Related Bone Morphogenetic Protein-2.

Authors:  Wenqi Song; Kunzheng Wang; Wei Wang; Pei Yang; Xiaoqian Dang
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

7.  Structural Identification and Systematic Comparison of Phorbol Ester, Dioleoylglycerol, Alcohol and Sevoflurane Binding Sites in PKCδ C1A Domain.

Authors:  Lijie Shi
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

8.  Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2.

Authors:  Xiaohua Fan; Hai Xia; Xiaoyun Liu; Benying Li; Jun Fang
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

9.  Computational Design of Antiangiogenic Peptibody by Fusing Human IgG1 Fc Fragment and HRH Peptide: Structural Modeling, Energetic Analysis, and Dynamics Simulation of Its Binding Potency to VEGF Receptor.

Authors:  Lin Ning; Zhongyan Li; Zhengya Bai; Shasha Hou; Bifang He; Jian Huang; Peng Zhou
Journal:  Int J Biol Sci       Date:  2018-05-22       Impact factor: 6.580

10.  Electrostatic explanation of D1228V/H/N-induced c-Met resistance and sensitivity to type I and type II kinase inhibitors in targeted gastric cancer therapy.

Authors:  Zhen Xu; Pingping Hu; Dong Fang; Lingna Ni; Jianzhong Xu
Journal:  J Mol Model       Date:  2019-01-03       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.